Stockscreener 앱 받기
1.08
8.00%
0.08
시간 외 거래:
1.08
Shattuck Labs Inc 주식(STTK)의 최신 뉴스
Peritoneal Cancer Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
Dimensional Fund Advisors LP Sells 109,300 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $7.50 Average PT from Brokerages - Defense World
LAWSUITS FILED AGAINST STTK, ASTR and CELHJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Lawsuits Filed Against STTK, EDU and ASTR – Jakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
LAWSUITS FILED AGAINST BMBL, STTK and SPWRJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
LAWSUITS FILED AGAINST STTK, RIVN and AIJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Renaissance Technologies LLC Reduces Stock Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Renaissance Technologies LLC Sells 222,500 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - The AM Reporter
Shattuck Labs Advances SL-325 Program Amid Financial Progress - TipRanks
LAWSUITS FILED AGAINST FSLR, CLVT and STTKJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Shattuck Labs, Inc. (NASDAQ:STTK) Shares Bought by JPMorgan Chase & Co. - Defense World
Shattuck Labs First Quarter 2025 Earnings: US$0.27 loss per share (vs US$0.37 loss in 1Q 2024) - Yahoo Finance
STTK Prepares for Phase 1 Clinical Trial of SL-325 | STTK Stock News - GuruFocus
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times
Shattuck Labs Inc (STTK) Reports Q1 2025 EPS of -$0.27, Narrowly Beating Estimates - GuruFocus
Shattuck Labs Reports First Quarter 2025 Financial Results and R - GuruFocus
Shattuck Labs, Inc. SEC 10-Q Report - TradingView
Shattuck Labs Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
STTK STOCK ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
Lawsuits Filed Against CHGG, STTK and EDUJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Google Earnings: The One Metric That No One Saw Coming - The Globe and Mail
Shattuck Labs (STTK) to Release Earnings on Thursday - Defense World
HVAC and Water Systems Stocks Q4 In Review: Advanced Drainage (NYSE:WMS) Vs Peers - The Globe and Mail
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $7.50 Average Price Target from Analysts - Defense World
Shattuck Labs at 24th Annual Needham Conference: Strategic IBD Focus By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
3 Promising Penny Stocks With Market Caps Under $300M - simplywall.st
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Acute Myeloid Leukemia Treatment Market 2034: Clinical Trials, - openPR.com
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times
24,446 Shares in Shattuck Labs, Inc. (NASDAQ:STTK) Acquired by Virtu Financial LLC - Defense World
Biotech Spotlight: Shattuck Labs CEO Set for Major Investor Presentation at Needham Conference - Stock Titan
STTK stock plunges to 52-week low, touches $0.93 - Investing.com
Brokers Issue Forecasts for Shattuck Labs Q1 Earnings - Defense World
515,619 Shares in Shattuck Labs, Inc. (NASDAQ:STTK) Acquired by Takeda Pharmaceutical Co. Ltd. - MarketBeat
H.C. Wainwright holds Shattuck Labs stock at Neutral - Investing.com
Shattuck Labs Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Shattuck Labs (NASDAQ:STTK) Given Neutral Rating at HC Wainwright - Defense World
Shattuck Labs’ (STTK) “Hold” Rating Reaffirmed at Needham & Company LLC - Defense World
Shattuck Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Shattuck Labs Inc (STTK) Q4 2024 Earnings: EPS of -$0.37 Misses Estimate, Revenue of $0.71M Below Expectations - GuruFocus
17.27%
1.06%
자본화:
|
볼륨(24시간):